Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.150
0.00 (0.00%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $19.56 million as of September 26, 2025. Its market cap has decreased by -79.58% in one year.
Market Cap
19.56M
Enterprise Value
15.36M
1-Year Change
-79.58%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $19.56M, a decrease of -36.27%. That is a compound annual growth rate of -5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 19.60M | -36.57% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |